Integrated Core Strategies (US) LLC 13D and 13G filings for ANI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 4:28 pm Sale | 2025-09-30 | 13G | ANI PHARMACEUTICALS INC ANIP | Integrated Core Strategies (US) LLC | 65,245 0.300% | -1,051,415 (-94.16%) | Filing |
| 2025-06-04 4:00 pm Purchase | 2025-05-30 | 13G | ANI PHARMACEUTICALS INC ANIP | Integrated Core Strategies (US) LLC | 1,116,660 5.200% | 598,728 (+115.60%) | Filing |